Zhi-Heng Chen et al. 2021. Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People. Newest Updates in Physical Science Research Vol. 5. (May 2021), 36–65. DOI:https://doi.org/10.9734/bpi/nupsr/v5/1960F.